Despite the availability of multiple public health interventions, approximately 608,000 malaria deaths were recorded in 2022, with the majority of these deaths occurring in children under 5 years of age.…
Read More
Life-long ART presents new challenges of treatment fatigue and long-term toxicities, and the growing population in need of ART pose critical public health questions over the long-term financial sustainability of…
Read More
The combination of CAB LA and RPV LA has been shown in clinical trials in virologically suppressed adults living with HIV to be safe, well-tolerated and efficacious as a complete…
Read More
Adolescents have poorer treatment outcomes including higher loss to follow-up, lower treatment adherence, poorer virological suppression and higher mortality than older people living with HIV. Some of the adherence challenges…
Read More
This is a Phase III, open-label, multi-center trial with a cluster-randomized superiority design. The purpose of the study is to compare the efficacy and safety of 26 weeks of Delamanid…
Read More
It is a Phase 2/3, Open-Label Study to confirm the dose of elvitegravir/cobicistat/emtricitabin e/tenofoviralafenamide (E/C/F/TAF) single tablet regimen (STR) in HIV-1 infected, antiretroviral (ARV) treatment naive adolescents and evaluate the…
Read More
